IMRF
ITCI

Illinois Municipal Retirement Fund’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Illinois Municipal Retirement Fund’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,091
Closed -$470K – 833
2022
Q3 		$470K Hold
10,091
– – 0.01% 773
2022
Q2 		$576K Buy
+10,091
New +$572K 0.01% 731

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Illinois Municipal Retirement Fund's ITCI Position: Q4 2022 in Review

Illinois Municipal Retirement Fund sold out of Intra-Cellular Therapies Inc. (ITCI) in Q4 2022, closing a stake of 10,091 shares — an estimated $470K sold.

Illinois Municipal Retirement Fund first reported a position in ITCI in Q2 2022 and held it in 2 quarters. The position peaked at $576K in Q2 2022. 283 funds tracked by Wall St. Rank hold ITCI as of Q4 2022.

  • Illinois Municipal Retirement Fund reported no remaining Intra-Cellular Therapies Inc. position as of Q4 2022 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 10,091 Intra-Cellular Therapies Inc. shares in Q4 2022, an estimated $470K.
  • Illinois Municipal Retirement Fund first reported a position in Intra-Cellular Therapies Inc. in Q2 2022 and held it in 2 quarters.
  • Illinois Municipal Retirement Fund's Intra-Cellular Therapies Inc. position peaked at $576K in Q2 2022.
  • 283 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q4 2022.

Based on Illinois Municipal Retirement Fund's 13F filing for Q4 2022, filed 3 Feb 2023.